What was the nature and value of the equity award granted to Chemours director George R. Brokaw on May 6, 2026?

George R. Brokaw, a director of Chemours Co (NYSE: CC), was granted 7,182 shares of Common Stock on May 6, 2026, as an equity award with a reported price of $0.00 per share; this transaction was a form of compensation, not a market purchase, and involved no derivative securities.

How did the equity award affect George R. Brokaw’s total direct holdings in Chemours as of the filing?

The equity award increased George R. Brokaw’s direct holdings—including deferred stock units and dividend equivalent units—to a total of 21,642.7173 shares, as disclosed in the Form 4 filing.